Announcements Trials

Browse Landscape

Phase

Phase 3 4 Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

ER+ HER2- Advanced Breast Cancer 1

Interventions

pembrolizumab 79 Cyclophosphamide 55 Specimen Handling 54 Carboplatin 50 fludarabine 44 Nivolumab 42 Magnetic Resonance Spectroscopy 42 Biopsy 38 Gemcitabine 37 Bevacizumab 34 Dexamethasone 31 venetoclax 27 Paclitaxel 26 Injections 25 Docetaxel 25 atezolizumab 24 Pemetrexed 24 Cisplatin 24 Ipilimumab 23 Capecitabine 21 Temozolomide 19 Fulvestrant 19 abemaciclib 18 Rituximab 18 Oxaliplatin 18 Lenalidomide 18 Cetuximab 18 Azacitidine 18 Vincristine 15 Fluorouracil 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × AZD9833 × 90 days × Clear all

NCT06188520 2026-05-11

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting

BreastGynecologic

ER+ HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡